[BsoAI--a new site specific endonuclease from Bacillus coagulans]

Area of Science:

• * Molecular Biology
• * Biochemistry
• * Microbiology

Background:

• * Site-specific endonucleases are crucial tools in molecular biology for DNA manipulation.
• * Bacillus coagulans is a bacterial species with potential for novel enzyme discovery.

Purpose of the Study:

• * To identify and characterize a novel restriction endonuclease from Bacillus coagulans AUCM B-732.
• * To determine the DNA recognition sequence and cleavage pattern of the new enzyme, BcoAI.
• * To investigate its potential as an isoschizomer of known enzymes.

Main Methods:

• * Enzyme purification using a combination of PEG/dextran fractionation and ion-exchange chromatography (DEAE-sepharose, phosphocellulose).
• * Nuclease and phosphatase activity assays to confirm enzyme purity.
• * DNA cleavage analysis using various DNA substrates (lambda DNA, SV40, pBR322, pUC19).

Main Results:

• * A novel site-specific endonuclease, BcoAI, was purified from Bacillus coagulans AUCM B-732.
• * BcoAI recognizes and cleaves the DNA sequence 5' CAC GTG 3' producing blunt ends.
• * The enzyme exhibits specificity, cleaving lambda DNA but not SV40, pBR322, or pUC19 DNA.
• * BcoAI was confirmed as a true isoschizomer of PmaCI.

Conclusions:

• * BcoAI is a novel blunt-end producing restriction enzyme with a specific recognition site.
• * Its characterization expands the repertoire of available restriction enzymes for molecular cloning and genetic engineering.
• * The identification of BcoAI as an isoschizomer of PmaCI provides an alternative source for this enzyme.